The global irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2020 to 2028.
Increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics developments are the factors driving the global irritable bowel syndrome (IBS) diagnostics market. However, the challenges in diagnosis of IBS are hindering the market growth.
Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.
Irritable bowel syndrome is a chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping.
People across the world are witnessing considerable incidence of irritable bowel syndrome. According to the data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients, about 40% of people have mild IBS, around 35% have moderate IBS, and an estimated 25% have severe IBS. Food allergies, developing stages of gastroenteritis, sporadic movements of colon, a billion ormal composition of serotonin in colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. According to a study published on NCBI in 2018, irritable bowel syndrome is estimated to affect around 10-16% of the US population each year. Further, as per the IBS Global Impact Report, in 2016, an estimated mean prevalence of individual countries ranged from 1.1% in France and Iran to 35.5% in Mexico. Latin America had a prevalence rate of 17.5%, Asia 9.6%, North America/Europe/Australia/New Zealand 7.1%, and the Middle East & Africa had a prevalence rate of 5.8%. Such staggering prevalence of irritable bowel syndrome is likely to boost the irritable bowel syndrome (IBS) diagnostics market during the forecast period.
Diagnosis Insights
Based on diagnosis, the global irritable bowel syndrome (IBS) diagnostics market is segmented into laboratory tests and imaging tests. In 2020, the laboratory tests segment held the largest share in the market. Moreover, the segment is expected to hold the largest market share by 2028. The market growth is mainly attributed to the growing prevalence of irritable bowel syndrome (IBS) worldwide, which is likely to continue in the coming years due to disturbances in bowel habits and abdominal pain. This, in turn, is boosting the demand for diagnosis of these diseases worldwide.
Indication Insights
Based on indication, the global irritable bowel syndrome (IBS) diagnostics market is segmented into pain and cramping, diarrhea, constipation, and alternating constipation and diarrhea. The pain and cramping segment held the largest market share in 2020, and it is further expected to dominate the market by 2028. Antispasmodics and antidepressants are medication used to treat IBS pain and cramping.
Major primary and secondary sources referred to while preparing the report on the global irritable bowel syndrome (IBS) diagnostics market are the Food and Drug Administration (FDA), National Center for Biotechnology Information (NCBI), American Society for Gastrointestinal Endoscopy, International Foundation for Gastrointestinal Disorders, World Journal of Gastroenterology, International Foundation for Gastrointestinal Disorders, Inc. (IFFGD), Canadian Digestive Health Foundation, Gastrointestinal Society, and The Korean Society of Neurogastroenterology and Motility, among others.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
 1.3.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market - By Diagnosis
 1.3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market - By Indication
 1.3.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Market- By Geography
2. Irritable Bowel Syndrome (IBS) Diagnostics Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Irritable Bowel Syndrome (IBS) Diagnostics Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
 4.2.1 North America PEST Analysis
 4.2.2 Europe PEST Analysis
 4.2.3 APAC PEST Analysis
 4.2.4 MEA PEST Analysis
 4.2.5 SCAM PEST Analysis
4.3 Expert Opinion
5. Irritable Bowel Syndrome (IBS) Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
 5.1.1 Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
 5.1.2 Increasing number of FDA approvals and diagnostics developments
5.2 Market Restraint
 5.2.1 Challenges in Diagnosis of IBS
5.3 Market Opportunity
 5.3.1 Increasing disposable incomes of the population
5.4 Future Trend
 5.4.1 Development of medical devices for the diagnosis of irritable bowel syndrome
5.5 Impact analysis
6. Irritable Bowel Syndrome (IBS) Diagnostics Market- Global Analysis
6.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Forecast and Analysis
6.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis- by Diagnosis
7.1 Overview
7.2 Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
7.3 Laboratory Tests
 7.3.1 Overview
 7.3.2 Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
 7.3.3 Lactose Intolerance Tests
 7.3.3.1 Overview
 7.3.3.2 Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
 7.3.4 Breath Test for Bacterial Overgrowth
 7.3.4.1 Overview
 7.3.4.2 Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
 7.3.5 Stool Tests
 7.3.5.1 Overview
 7.3.5.2 Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
 7.3.6 Blood Tests
 7.3.6.1 Overview
 7.3.6.2 Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
 7.4.1 Overview
 7.4.2 Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
 7.4.3 CT-Scan or X-Ray
 7.4.3.1 Overview
 7.4.3.2 CT-Scan or X-Ray: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
 7.4.4 Upper Endoscopy
 7.4.4.1 Overview
 7.4.4.2 Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
 7.4.5 Colonoscopy
 7.4.5.1 Overview
 7.4.5.2 Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis - By Indication
8.1 Overview
8.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)
8.3 Pain and Cramping
 8.3.1 Overview
 8.3.2 Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Diarrhea
 8.4.1 Overview
 8.4.2 Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Constipation
 8.5.1 Overview
 8.5.2 Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Alternating Constipation and Diarrhea
 8.6.1 Overview
 8.6.2 Alternating Constipation and Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
9. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis and Forecasts To 2028 - Geographical Analysis
9.1 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market
 9.1.1 Overview
 9.1.2 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.1.3 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
 9.1.3.1 North America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.1.3.2 North America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.1.4 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, By Indication - Revenue and Forecast to 2028 (USD Million)
 9.1.5 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
 9.1.6 US: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.1.6.1 US: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.1.6.2 US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis- Revenue and Forecast to 2028 (USD Million)
 9.1.6.2.1 US: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.1.6.2.2 US: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.1.6.3 US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication- Revenue and Forecast to 2028 (USD Million)
 9.1.7 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.1.7.1 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.1.7.2 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis- Revenue and Forecast to 2028 (USD Million)
 9.1.7.2.1 Canada: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.1.7.2.2 Canada: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.1.7.3 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
 9.1.8 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.1.8.1 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.1.8.2 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
 9.1.8.2.1 Mexico: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.1.8.2.2 Mexico: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.1.8.3 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.2 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market
 9.2.1 Overview
 9.2.2 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.3 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
 9.2.3.1 Europe: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.3.2 Europe: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.4 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
 9.2.5 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028(%)
 9.2.6 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.6.1 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.6.2 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
 9.2.6.2.1 Germany: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.6.2.2 Germany: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.6.3 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
 9.2.7 France: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.7.1 France: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.7.2 France: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
 9.2.7.2.1 France: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.7.2.2 France: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.7.3 France: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
 9.2.8 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.8.1 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.8.2 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
 9.2.8.2.1 UK: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.8.2.2 UK: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.8.3 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
 9.2.9 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.9.1 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.9.2 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
 9.2.9.2.1 Italy: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.9.2.2 Italy: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.9.3 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
 9.2.10 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.10.1 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.10.2 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
 9.2.10.2.1 Spain: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.10.2.2 Spain: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.10.3 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
 9.2.11 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.11.1 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
 9.2.11.2 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
 9.2.11.2.1 Rest of Europe: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.11.2.2 Rest of Europe: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
 9.2.11.3 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)0
9.3 Asia Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market1
 9.3.1 Overview1
 9.3.2 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)2
 9.3.3 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)2
 9.3.3.1 Asia-Pacific: Laboratory Tests Market, by Type, 2019-2028 (USD Million)3
 9.3.3.2 Asia-Pacific: Imaging Tests Market, by Type, 2019-2028 (USD Million)3
 9.3.4 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)4
 9.3.5 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)4
 9.3.6 China: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)5
 9.3.6.1 China: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)5
 9.3.6.2 China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)6
 9.3.6.2.1 China: Laboratory Tests Market, by Type, 2019-2028 (USD Million)6
 9.3.6.2.2 China: Imaging Tests Market, by Type, 2019-2028 (USD Million)6
 9.3.6.3 China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)7
 9.3.7 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)8
 9.3.7.1 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)8
 9.3.7.2 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)9
 9.3.7.2.1 Japan: Laboratory Tests Market, by Type, 2019-2028 (USD Million)9
 9.3.7.2.2 Japan: Imaging Tests Market, by Type, 2019-2028 (USD Million)9
 9.3.7.3 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)9
 9.3.8 India: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)1
 9.3.8.1 India: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)1
 9.3.8.2 India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)2
 9.3.8.2.1 India: Laboratory Tests Market, by Type, 2019-2028 (USD Million)2
 9.3.8.2.2 India: Imaging Tests Market, by Type, 2019-2028 (USD Million)2
 9.3.8.3 India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)3
 9.3.9 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)4
 9.3.9.1 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)4
 9.3.9.2 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)5
 9.3.9.2.1 Australia: Laboratory Tests Market, by Type, 2019-2028 (USD Million)5
 9.3.9.2.2 Australia: Imaging Tests Market, by Type, 2019-2028 (USD Million)5
 9.3.9.3 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)6
 9.3.10 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)7
 9.3.10.1 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)7
 9.3.10.2 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)8
 9.3.10.2.1 South Korea: Laboratory Tests Market, by Type, 2019-2028 (USD Million)8
 9.3.10.2.2 South Korea: Imaging Tests Market, by Type, 2019-2028 (USD Million)9
 9.3.10.3 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)9
 9.3.11 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)0
 9.3.11.1 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)0
 9.3.11.2 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)1
 9.3.11.2.1 Rest of Asia-Pacific: Laboratory Tests Market, by Type, 2019-2028 (USD Million)1
 9.3.11.2.2 Rest of Asia-Pacific: Imaging Tests Market, by Type, by Imaging Tests, 2019-2028 (USD Million)2
 9.3.11.3 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)2
9.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market3
 9.4.1 Overview3
 9.4.2 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)4
 9.4.3 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)4
 9.4.3.1 Middle East and Africa: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)5
 9.4.3.2 Middle East and Africa: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)5
 9.4.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)6
 9.4.5 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)6
 9.4.6 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)7
 9.4.6.1 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)7
 9.4.6.2 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)8
 9.4.6.2.1 Saudi Arabia: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)8
 9.4.6.2.2 Saudi Arabia: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)8
 9.4.6.3 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)9
 9.4.7 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)0
 9.4.7.1 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)0
 9.4.7.2 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)1
 9.4.7.2.1 South Africa: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)1
 9.4.7.2.2 South Africa: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)1
 9.4.7.3 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)2
 9.4.8 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)3
 9.4.8.1 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)3
 9.4.8.2 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)4
 9.4.8.2.1 UAE: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)4
 9.4.8.2.2 UAE: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)5
 9.4.8.3 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)5
 9.4.9 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)6
 9.4.9.1 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)6
 9.4.9.2 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)7
 9.4.9.2.1 Rest of Middle East and Africa: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)7
 9.4.9.2.2 Rest of Middle East and Africa: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)7
 9.4.9.3 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)8
9.5 South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market9
 9.5.1 Overview9
 9.5.2 South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)0
 9.5.3 South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)0
 9.5.3.1 South And Central America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)1
 9.5.3.2 South And Central America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)1
 9.5.4 South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)2
 9.5.5 South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)3
 9.5.6 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)3
 9.5.6.1 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)3
 9.5.6.2 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)4
 9.5.6.2.1 Brazil: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)4
 9.5.6.2.2 Brazil: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)5
 9.5.6.3 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)5
 9.5.7 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)6
 9.5.7.1 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)6
 9.5.7.2 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)7
 9.5.7.2.1 Argentina: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)7
 9.5.7.2.2 Argentina: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)8
 9.5.7.3 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)8
 9.5.8 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)9
 9.5.8.1 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)9
 9.5.8.2 Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)0
 9.5.8.2.1 Rest of South And Central America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)0
 9.5.8.2.2 Rest of South And Central America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)1
 9.5.8.3 Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)1
10. Impact of COVID-19 Pandemic on Global Irritable Bowel Syndrome (IBS) Diagnostics Market2
10.1 North America: Impact Assessment of COVID-19 Pandemic2
10.2 Europe: Impact Assessment of COVID-19 Pandemic4
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic6
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic7
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic8
11. Irritable Bowel Syndrome (IBS) Diagnostics Market- Industry Landscape9
11.1 Overview9
11.2 Growth Strategies Done by the Companies in the Market, (%)9
11.3 Organic Developments0
 11.3.1 Overview0
11.4 Inorganic Developments1
 11.4.1 Overview1
12. Company Profiles2
12.1 Commonwealth Diagnostics International2
 12.1.1 Key Facts2
 12.1.2 Business Description2
 12.1.3 Products and Services2
 12.1.4 Financial Overview2
 12.1.5 SWOT Analysis3
 12.1.6 Key Developments3
12.2 Genova Diagnostics5
 12.2.1 Key Facts5
 12.2.2 Business Description5
 12.2.3 Products and Services5
 12.2.4 Financial Overview5
 12.2.5 SWOT Analysis6
 12.2.6 Key Developments6
12.3 Gemelli Biotech7
 12.3.1 Key Facts7
 12.3.2 Business Description7
 12.3.3 Products and Services7
 12.3.4 Financial Overview7
 12.3.5 SWOT Analysis8
 12.3.6 Key Developments8
12.4 Prometheus Laboratories9
 12.4.1 Key Facts9
 12.4.2 Business Description9
 12.4.3 Products and Services9
 12.4.4 Financial Overview9
 12.4.5 SWOT Analysis0
 12.4.6 Key Developments0
12.5 Inova Diagnostics, Inc.1
 12.5.1 Key Facts1
 12.5.2 Business Description1
 12.5.3 Products and Services1
 12.5.4 Financial Overview1
 12.5.5 SWOT Analysis2
 12.5.6 Key Developments2
12.6 Biohit Oyj3
 12.6.1 Key Facts3
 12.6.2 Business Description3
 12.6.3 Products and Services3
 12.6.4 Financial Overview4
 12.6.5 SWOT Analysis5
 12.6.6 Key Developments5
12.7 Aerodiagnostics, LLC.6
 12.7.1 Key Facts6
 12.7.2 Business Description6
 12.7.3 Products and Services6
 12.7.4 Financial Overview6
 12.7.5 SWOT Analysis7
 12.7.6 Key Developments7
12.8 Metabolic Solutions, Inc.8
 12.8.1 Key Facts8
 12.8.2 Business Description8
 12.8.3 Products and Services8
 12.8.4 Financial Overview8
 12.8.5 SWOT Analysis9
 12.8.6 Key Developments9
12.9 Sysmex Corporation (Sysmex Europe GmbH)9
 12.9.1 Key Facts9
 12.9.2 Business Description9
 12.9.3 Products and Services0
 12.9.4 Financial Overview0
 12.9.5 SWOT Analysis2
 12.9.6 Key Developments2
12.10 B?HLMANN Laboratories AG3
 12.10.1 Key Facts3
 12.10.2 Business Description3
 12.10.3 Products and Services3
 12.10.4 Financial Overview3
 12.10.5 SWOT Analysis4
 12.10.6 Key Developments4
13. Appendix5
13.1 About the Insight Partners5
13.2 Glossary of Terms5
LIST OF TABLES
Table 1. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, By Indication - Revenue and Forecast to 2028 (USD Million)
Table 5. US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis- Revenue and Forecast to 2028 (USD Million)
Table 6. US: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 7. US: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 8. US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication-Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis- Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 18. Europe: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 19. Europe: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 20. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 21. Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 22. Germany: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. Germany: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 24. Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 25. France: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 26. France: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 27. France: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 28. France: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 29. UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 30. UK: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 31. UK: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 32. UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 33. Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 34. Italy: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 35. Italy: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 36. Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 37. Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 38. Spain: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 39. Spain: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 40. Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Europe: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 43. Rest of Europe: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 44. Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)0
Table 45. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)2
Table 46. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)3
Table 47. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)3
Table 48. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)4
Table 49. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)6
Table 50. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)6
Table 51. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)6
Table 52. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)7
Table 53. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)9
Table 54. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)9
Table 55. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)9
Table 56. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)0
Table 57. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)2
Table 58. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)2
Table 59. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)2
Table 60. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)3
Table 61. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)5
Table 62. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)5
Table 63. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)5
Table 64. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)6
Table 65. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Foreca
LIST OF FIGURES
Commonwealth Diagnostics International
Genova Diagnostics
Gemelli Biotech
Prometheus Laboratories
Inova Diagnostics, Inc.
Biohit Oyj
Aerodiagnostics, LLC.
Metabolic Solutions, Inc.
Sysmex Corporation
B?HLMANN Laboratories AG.